Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes

被引：10

作者：

Gelsi-Boyer, V.

Cervera, N.

Bertucci, F.

Trouplin, V.

Remy, V.

Olschwang, S.

Chaffanet, M.

Vey, N.

Mozziconacci, M-J.

Birnbaum, D. ^{[1
]}

机构：

[1] Inst Paoli Calmettes, Ctr Canc Res, Oncol Mol Lab, Marseille, France

[2] Inst Paoli Calmettes, Dept Biopathol, Marseille, France

[3] Univ Mediterranee, Marseille, France

[4] Inst Paoli Calmettes, Dept Hematol, Marseille, France

来源：

LEUKEMIA | 2007年 / 21卷 / 11期

关键词：

D O I：

10.1038/sj.leu.2404805

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2359 / 2362

页数：5

共 10 条

[1] THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, H ;

SULTAN, C ;

COX, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :746-754

[2] Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined [J].

Elliot, Michelle A. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (03) :571-593

[3] Problems in the classification of CMML - dysplastic versus proliferative type [J].

Germing, U ;

Gattermann, N ;

Minning, H ;

Heyll, A ;

Aul, C .

LEUKEMIA RESEARCH, 1998, 22 (10) :871-878

[4] Two groups of chronic myelomonocytic leukaemia:: myelodysplastic and myeloproliferative.: Prognostic implications in a series of a single center [J].

González-Medina, I ;

Bueno, J ;

Torrequebrada, A ;

López, A ;

Vallespí, T ;

Massagué, I .

LEUKEMIA RESEARCH, 2002, 26 (09) :821-824

[5] Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators [J].

Lelievre, H. ;

Cervera, N. ;

Finetti, P. ;

Delhommeau, F. ;

Vainchenker, W. ;

Bertucci, F. ;

Birnbaum, D. .

LEUKEMIA, 2006, 20 (10) :1885-1888

[6] Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease [J].

Magrangeas, F ;

Nasser, V ;

Avet-Loiseau, H ;

Loriod, B ;

Decaux, O ;

Granjeaud, S ;

Bertucci, F ;

Birnbaum, D ;

Nguyen, C ;

Harousseau, JL ;

Bataille, R ;

Houlgatte, F ;

Minvielle, S .

BLOOD, 2003, 101 (12) :4998-5006

[7] Dysplastic versus proliferative CMML -: a retrospective analysis of 91 patients from a single institution [J].

Nösslinger, T ;

Reisner, R ;

Grüner, H ;

Tüchler, H ;

Nowotny, H ;

Pittermann, E ;

Pfeilstöcker, M .

LEUKEMIA RESEARCH, 2001, 25 (09) :741-747

[8] Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients [J].

Onida, F ;

Kantarjian, HM ;

Smith, TL ;

Ball, G ;

Keating, MJ ;

Estey, EH ;

Glassman, AB ;

Albitar, M ;

Kwari, MI ;

Beran, M .

BLOOD, 2002, 99 (03) :840-849

[9] Diagnosis of multiple cancer types by shrunken centroids of gene expression [J].

Tibshirani, R ;

Hastie, T ;

Narasimhan, B ;

Chu, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6567-6572

[10] The World Health Organization (WHO) classification of the myeloid neoplasms [J].

Vardiman, JW ;

Harris, NL ;

Brunning, RD .

BLOOD, 2002, 100 (07) :2292-2302

← 1 →